p3E entry vector for Three Multisite Gateway

AAV packaging plasmid, expressing Rep2 and AAV-cMG capsid

cdGreen2.1 (optimized for Pseudomonas GC-content) expressed from a constitutive promoter in an operon with mScarlet-I (downstream) as a reference FP (Internal Lab ID: UJ11241)

Mammalian expression of human GSK3 beta constitutively active mutant with HA tag

Mammalian expression of human GSK3 beta constitutively active mutant with HA tag

Gateway entry 1A vector, no ccDB gene

Gateway entry 1A vector, no ccDB gene

Broad-Host range expression vector, RK2 and pUC origin, AraC activator/repressor, PBAD promoter, mRFP, Gentamicin Resistance Marker.

Inducibly expresses mouse RipK3 fused to light activatable Cry2

PiggyBac cargo vector expressing rtTA. Also confers resistance to G418.

An improved vector for BacMam system

Expression of human CD79A as RFP fusion protein

tRNA synthetase/tRNA pair for the in vivo incorporation of several non-standard amino acids, into proteins in E coli in response to the amber codon, TAG

Bacterial expression plasmid of anti-mouse IgG2a Fc nanobody TP1129 (3x Cysteines)

Ready-to-use AAV Retrograde particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.